By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
Currency | Euro |
Share Price | 85.80 |
Change Today | -1.00 |
% Change | -1.16 % |
52 Week High | 109.62 |
52 Week Low | 77.52 |
Volume | 368,768 |
Shares Issued | 1,256.00m |
Market Cap | 107,760m |
Beta | 0.79 |
Time | Volume / Share Price |
12:24 | 19 @ 85.78 |
12:23 | 63 @ 85.77 |
12:23 | 2 @ 85.77 |
12:23 | 10 @ 85.78 |
12:23 | 26 @ 85.78 |
You are here: research